Pharmacokinetics [phsf]
Raloxifene [orch, phsu]
Application [hlca]
Hormone replacement therapy [topp]
Administered [ftcn]
postmenopausal [tmco]
Women [popg]
Relieves [ftcn]
Climacteric [orgf]
symptoms [ftcn]
PREVENT [phsu]
Loss [qnco]
bone mass [clna]
coronary artery disease [dsyn]
Benefits [qnco]
Hormone replacement therapy [topp]
Following [tmco]
therapy [ftcn]
Compliance [qnco]
Regimen [topp]
reasons [idcn]
Uterine Bleeding [patf]
Pains, Breast [sosy]
Fear [menp]
Breast Cancer [neop]
Hormone replacement therapy [topp]
Increased [qnco]
Breast Cancer [neop]
Need [qlco]
Ideal [qlco]
Estrogen [horm, phsu, strd]
Design [acty]
desire [menp]
Target [ftcn]
Tissues [tisu]
Estrogen [horm, phsu, strd]
Bone [bpoc]
ACT [topp]
Antiestrogen [phsu]
Uterus [bpoc]
Breast tissue [bpoc]
Raloxifene [orch, phsu]
Class [inpr]
Compound [qlco]
Selective Estrogen Receptor Modulators [horm, phsu]
Bind [acty]
Estrogen Receptors [aapp, rcpt]
ACT [topp]
Estrogen [horm, phsu, strd]
Agonist [phsu]
Bone [bpoc]
Estrogen antagonist [phsu]
In [qnco]
Breast [bpoc]
Uterus [bpoc]
Raloxifene [orch, phsu]
Represent [acty]
Alternative [cnce]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
Prevention [topp]
treatment [ftcn]
Osteoporosis [dsyn]
Cardiovascular disease [dsyn]
Clinical Studies [resa]
drug term [inpr]
Long [qlco]
Benefit [qnco]
Required [ftcn]
Science [ocdi]
Ireland [geoa]
LTD [ortf]
Reserve [acty]
